XBiotech Inc. — Director's Dealing 2021

Oct 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-10-07

Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-07	Common Stock	S	39286	$12.45	Disposed	3923166	Direct
2021-10-12	Common Stock	S	18000	$12.7744	Disposed	3973166	Direct
2021-10-13	Common Stock	S	10875	$12.83	Disposed	3962452	Direct
2021-10-14	Common Stock	S	21125	$12.9005	Disposed	3873166	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.